文献速递甲状腺疾病

甲状腺结节无诊断性细针穿刺活检:结局与决定因素

Nondiagnostic Fine-Needle Aspiration Biopsy of Thyroid Nodules: Outcomes and Determinants.
PubMed 文献 · Thyroid · 2020-02-26

单中心队列研究纳入2007年5月至2013年6月期间2234例首次超声引导下甲状腺结节细针穿刺活检者,分析无诊断性结果的发生率、预测因素及恶性诊断率。首次活检诊断率84.4%,第一次重复活检降至57.6%,第二次重复活检降至42.4%;无诊断性活检后恶性诊断率为8.1%,且与既往无诊断性穿刺次数无关。

要点

  • 首次细针穿刺诊断率为84.4%,第一次重复穿刺降至57.6%,第二次重复穿刺降至42.4%。
  • 既往穿刺次数越多,无诊断性细针穿刺的调整风险越高,白人中也更高。
  • 无诊断性细针穿刺后恶性诊断率为8.1%,且与既往无诊断性穿刺次数无关。

核心结论

  • 首次无诊断性细针穿刺后,每次序贯重复穿刺获得诊断性结果的概率下降。
  • 尽管重复无诊断性细针穿刺后仍存在恶性可能。

研究设计与样本

  • 单中心队列研究,纳入2007年5月至2013年6月在Beth Israel Deaconess Medical Center甲状腺结节门诊所有首次超声引导下细针穿刺活检者2234例。
  • 分析人口学数据、随访超声、重复细针穿刺及组织病理学结果。
  • 使用广义估计方程分析无诊断状态的潜在预测因素,并以精确二项置信区间计算诊断性结果及恶性概率。

主要发现

  • 首次细针穿刺获得诊断性活检的概率为84.4%[95%CI 82.8-85.8%],第一次重复穿刺为57.6%[CI 50.8-64.2%],第二次重复穿刺为42.4%[CI 25.5-60.8%]。
  • 无诊断性细针穿刺的调整风险随既往活检次数增加而显著升高,白人中亦更高。
  • 无诊断性细针穿刺后恶性诊断总体率为8.1%[CI 4.2-13.7%],且与既往无诊断性穿刺次数无关。

关键数值与推荐

  • 首次细针穿刺诊断性概率84.4%[95%CI 82.8-85.8%]。
  • 第一次重复细针穿刺诊断性概率57.6%[CI 50.8-64.2%]。
  • 第二次重复细针穿刺诊断性概率42.4%[CI 25.5-60.8%]。
  • 无诊断性细针穿刺后恶性诊断率8.1%[CI 4.2-13.7%]。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Nondiagnostic results are common following fine-needle aspiration biopsy (FNAB) of thyroid nodules, but recommendations for the management of these patients vary. We sought to determine the outcomes and predictors of nondiagnostic FNABs in a single-center cohort of patients undergoing thyroid nodule evaluation. Methodology: We identified all first time ultrasound-guided FNABs performed between May 2007 and June 2013 at the Beth Israel Deaconess Medical Center Thyroid Nodule Clinic and examined demographic data, follow-up ultrasounds, repeated FNABs, and histopathologic findings. We examined the likelihood of diagnostic findings and of cancer with increasing numbers of nondiagnostic evaluations with their exact binomial confidence intervals [CIs] and potential predictors of nondiagnostic status using generalized estimating equations. Results: During the six-year period, 2234 unique individuals underwent ultrasound-guided FNAB of a thyroid nodule. The probability of obtaining a diagnostic biopsy declined from 84.4% [95% CI 82.8-85.8%] for initial FNABs to 57.6% [CI 50.8-64.2%] for the first re-FNAB and further to 42.4% [CI 25.5-60.8%] for second re-FNABs. Adjusted risk of nondiagnostic FNAB strongly increased with increasing numbers of previous biopsies and was also higher among whites. The overall rate of diagnosis of malignancy after a nondiagnostic FNAB was 8.1% [CI 4.2-13.7%] and was similar regardless of the number of previous nondiagnostic aspirations. Conclusion: Following an initial nondiagnostic FNAB, the probability of yielding a diagnostic result declines with each sequential repeat FNAB. Nonetheless, a tangible possibility of malignancy remains even after repeated nondiagnostic FNABs.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Jack GA, Sternberg SB, Aronson MD, et al. Nondiagnostic Fine-Needle Aspiration Biopsy of Thyroid Nodules: Outcomes and Determinants. Thyroid. 2020. PMID: 31950884. doi:10.1089/thy.2019.0140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。